Business Description
Sinocelltech Group Ltd
ISIN : CNE100003ZL3
Share Class Description:
SHSE:688520: Class ATotal Employee Number:
2,200Compare
Compare
Traded in other countries / regions
688520.China Index Membership
SSE Composite IndexCSI 500 Index IPO Date
2020-06-22Description
Sinocelltech Group Ltd is one of Chin's biopharma companies specializing in biologics and vaccines. The company's therapeutic areas include oncology, immunology and inflammation, ophthalmology, and prophylactic vaccines. The company has developed technology platforms in protein expression vectors, cell line development, serum-free medium development, stoichiometrically controlled fed-batch cell culture, process scale-up, and protein purification. The capabilities of the company include stable CHO cell line development, cell banking and certification, serum-free and protein-free culture medium development, fed-batch cell culture process development, optimization, and process scale-up, protein purification development, and large scale production.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.5 | |||||
Equity-to-Asset | 0.19 | |||||
Debt-to-Equity | 3.7 | |||||
Debt-to-EBITDA | -4.33 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.11 | |||||
Beneish M-Score | -3.44 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 15.8 | |||||
3-Year EBITDA Growth Rate | 6.1 | |||||
3-Year EPS without NRI Growth Rate | -12 | |||||
3-Year FCF Growth Rate | 20.1 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 42.26 | |||||
9-Day RSI | 46.83 | |||||
14-Day RSI | 48 | |||||
3-1 Month Momentum % | -17.63 | |||||
6-1 Month Momentum % | -26.18 | |||||
12-1 Month Momentum % | -56.55 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.98 | |||||
Quick Ratio | 0.85 | |||||
Cash Ratio | 0.59 | |||||
Days Inventory | 1015.94 | |||||
Days Sales Outstanding | 174.32 | |||||
Days Payable | 399.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -2.29 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 91.58 | |||||
Operating Margin % | -38.06 | |||||
Net Margin % | -58.98 | |||||
EBITDA Margin % | -53.14 | |||||
FCF Margin % | -37.85 | |||||
OCF Margin % | -19.18 | |||||
ROE % | -323.58 | |||||
ROA % | -21.06 | |||||
ROIC % | -12.72 | |||||
3-Year ROIIC % | -3.08 | |||||
ROC (Joel Greenblatt) % | -32.28 | |||||
ROCE % | -59.4 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 34.84 | |||||
PS Ratio | 10.96 | |||||
PB Ratio | 19.57 | |||||
Price-to-Tangible-Book | 25.53 | |||||
EV-to-EBIT | -25.35 | |||||
EV-to-EBITDA | -25.35 | |||||
EV-to-Revenue | 13.47 | |||||
EV-to-FCF | -35.59 | |||||
Price-to-GF-Value | 0.96 | |||||
Earnings Yield (Greenblatt) % | -3.94 | |||||
FCF Yield % | -3.11 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sinocelltech Group Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,363.608 | ||
| EPS (TTM) (Â¥) | -1.836 | ||
| Beta | 1.5094 | ||
| 3-Year Sharpe Ratio | -0.2 | ||
| 3-Year Sortino Ratio | -0.33 | ||
| Volatility % | 36.78 | ||
| 14-Day RSI | 48 | ||
| 14-Day ATR (Â¥) | 2.138403 | ||
| 20-Day SMA (Â¥) | 36.685 | ||
| 12-1 Month Momentum % | -56.55 | ||
| 52-Week Range (Â¥) | 31.35 - 81.88 | ||
| Shares Outstanding (Mil) | 470.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sinocelltech Group Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sinocelltech Group Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sinocelltech Group Ltd Frequently Asked Questions
What is Sinocelltech Group Ltd(SHSE:688520)'s stock price today?
The current price of SHSE:688520 is ¥35.23. The 52 week high of SHSE:688520 is ¥81.88 and 52 week low is ¥31.35.
When is next earnings date of Sinocelltech Group Ltd(SHSE:688520)?
The next earnings date of Sinocelltech Group Ltd(SHSE:688520) is .
Does Sinocelltech Group Ltd(SHSE:688520) pay dividends? If so, how much?
Sinocelltech Group Ltd(SHSE:688520) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Sinocelltech Group Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers